Dr. Xia Yu is responsible for the company's overall strategic planning, business operations, and scientific development direction. Dr. Xia Yu holds...With over two decades of experience in biopharmaceutical research and development, Dr. Xia Yu is an expert in antibody drug development and a pioneer and leader in China's new era of biopharmaceutical innovation. In 2012, she founded Akeso, Inc., which has grown into one of China's leading biopharmaceutical companies. Prior to this, Dr. Xia held senior management positions at multinational pharmaceutical companies including Shanghai CrownBio, PDL BioPharma, Bayer (Germany), and CrownBio..

Dr. Xia Yu is a postdoctoral researcher at the University of Glasgow in the United Kingdom and holds a Ph.D. in Molecular Biology and Microbiology from Newcastle University, also in the UK. Dr. Xia Yu is a distinguished talent selected for China's National Major Talent Program and has been recognized by the Ministry of Science and Technology.A distinguished innovator and entrepreneur, recipient of the 7th China Overseas Chinese Contribution Award and featured on Forbes' "2020 Women in Tech" list.